Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PF-3882845

🥰Excellent
Catalog No. T16502Cas No. 1023650-66-9
Alias PF3882845

PF-3882845 is an orally available and selective salicorticoid receptor (MR) antagonist that binds to the progesterone receptor (PR) and can be used to study endocrine diseases and urogenital disorders.

PF-3882845

PF-3882845

🥰Excellent
Catalog No. T16502Alias PF3882845Cas No. 1023650-66-9
PF-3882845 is an orally available and selective salicorticoid receptor (MR) antagonist that binds to the progesterone receptor (PR) and can be used to study endocrine diseases and urogenital disorders.
Pack SizePriceAvailabilityQuantity
1 mg$85In Stock
5 mg$198In Stock
10 mg$293In Stock
25 mg$497In Stock
50 mg$831In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "PF-3882845"

Select Batch
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
PF-3882845 is an orally available and selective salicorticoid receptor (MR) antagonist that binds to the progesterone receptor (PR) and can be used to study endocrine diseases and urogenital disorders.
Targets&IC50
progesterone receptor:310 nM, mineralocorticoid receptor:2.7 nM
In vivo
In male Sprague-Dawley rats, PF-3882845 exhibited moderate bioavailability (F 86%) after oral administration (2 mg/kg). When administered intravenously (2 mg/kg), PF-3882845 exhibited a shorter terminal elimination half-life (T1/2 1.7 hours), which was associated with its higher plasma clearance (CL 9.8 mL/min/kg) and larger volume of distribution (Vdss 1.4 mL/kg).
PF-3882845 has hypotensive, urinary albumin-reducing and renoprotective effects in Dahl SS rats. [1]
AliasPF3882845
Chemical Properties
Molecular Weight419.9
FormulaC24H22ClN3O2
Cas No.1023650-66-9
SmilesClC=1C=C(N2[C@H]([C@@]3(C(=N2)C=4C(CC3)=CC(C(O)=O)=CC4)[H])C5CCCC5)C=CC1C#N
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 8 mg/mL (19.05 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3815 mL11.9076 mL23.8152 mL119.0760 mL
5 mM0.4763 mL2.3815 mL4.7630 mL23.8152 mL
10 mM0.2382 mL1.1908 mL2.3815 mL11.9076 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF-3882845 | purchase PF-3882845 | PF-3882845 cost | order PF-3882845 | PF-3882845 chemical structure | PF-3882845 in vivo | PF-3882845 formula | PF-3882845 molecular weight